Follicular lymphoma usually appears as painless, slowly growing lymph nodes. In the early stages of disease there are typically no symptoms, but at advanced stages the patient may experience ...

There is currently no standard first-line chemotherapy regimen for the treatment of patients with follicular lymphoma. A recent study by Gilles Salles et al. has shown that the combination of ...

Most follicular lymphoma cases exhibit classic clinicopathologic ... need to be differentiated from atypical lymphoid hyperplasia of the lymph nodes and tonsils. 5 FL variants with predominantly ...

What’s the next step for this patient with a 4-year history of low-grade follicular lymphoma and who ... for bilateral enlarged cervical lymph nodes, largest 4 x 5 cm, and bilateral inguinal ...

Distinction between atypical lymphoid proliferations with follicular pattern and follicular ... significant lymphadenopathy – that is, lymph nodes >2 cm in size – organomegaly (hepatomegaly ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

T cell-based immunotherapies, including CAR-T cell therapies, have significantly advanced treatment options for lymphomas such as diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Liso-cel, a CD19-directed chimeric antigen receptor T-cell product, and mosunetuzumab, a CD20/CD3 bispecific antibody, are used to treat patients with relapsed/refractory follicular lymphoma.